Monocytic leukemia
In Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96), chapter 2: Neoplasms
15 billable codes under C93: all are a CC; all map to HCC 20 (Lung and Other Severe Cancers), HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic).A CC or MCC (major CC) is a secondary diagnosis that raises the MS-DRG payment. An HCC counts toward a Medicare Advantage patient's risk score.
Advertisements
Instructional notes
Includes: conditions that are coded here
- monocytoid leukemia
Excludes1: not coded here, use a different code
- personal history of leukemia (Z85.6)
Also applies, from Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
These notes sit on C81-C96 and apply to every code under it, including C93.
Official coding guidelines
From the ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027 (CMS and NCHS). Links open the PDF at the right page.
Rules for coding benign and malignant neoplasms: using the Neoplasm Table, sequencing primary and secondary sites, treatment encounters, complications, and current cancer versus personal history.
- Admission/Encounter for treatment of primary site (page 33)
- Admission/Encounter for treatment of secondary site (page 33)
- Coding and sequencing of complications (page 34)
- Primary malignancy previously excised (page 34)
- Admissions/Encounters involving antineoplastic chemotherapy, immunotherapy and radiation therapy (page 35)
- Admission/encounter to determine extent of malignancy (page 36)
- Symptoms, signs, and abnormal findings listed in Chapter 18 associated with neoplasms (page 36)
- Admission/encounter for pain control/management (page 36)
All codes under C93
C93 can't be used on a claim. Pick a billable code below; grey headings group them.
- C93.0Acute monoblastic/monocytic leukemia
- C93.00Acute monoblastic/monocytic leukemia, not having achieved remission
- C93.01Acute monoblastic/monocytic leukemia, in remission
- C93.02Acute monoblastic/monocytic leukemia, in relapse
- C93.1Chronic myelomonocytic leukemia
- C93.10Chronic myelomonocytic leukemia not having achieved remission
- C93.11Chronic myelomonocytic leukemia, in remission
- C93.12Chronic myelomonocytic leukemia, in relapse
- C93.3Juvenile myelomonocytic leukemia
- C93.30Juvenile myelomonocytic leukemia, not having achieved remission
- C93.31Juvenile myelomonocytic leukemia, in remission
- C93.32Juvenile myelomonocytic leukemia, in relapse
- C93.9Monocytic leukemia, unspecified
- C93.90Monocytic leukemia, unspecified, not having achieved remission
- C93.91Monocytic leukemia, unspecified in remission
- C93.92Monocytic leukemia, unspecified in relapse
- C93.ZOther monocytic leukemia
- C93.Z0Other monocytic leukemia, not having achieved remission
- C93.Z1Other monocytic leukemia, in remission
- C93.Z2Other monocytic leukemia, in relapse
C93 MS-DRGs
As the principal diagnosis, the billable codes under C93 group to these 16 MS-DRGs (v44.0). Which one applies depends on procedures performed, secondary diagnoses (CC/MCC), and the patient's age and discharge status.
- DRG 820 Lymphoma and Leukemia with Major O.R. Procedures with MCC (15 of 15 codes)
- DRG 821 Lymphoma and Leukemia with Major O.R. Procedures with CC (15 of 15 codes)
- DRG 822 Lymphoma and Leukemia with Major O.R. Procedures without CC/MCC (15 of 15 codes)
- DRG 823 Lymphoma and Non-Acute Leukemia with Other Procedures with MCC (12 of 15 codes)
- DRG 824 Lymphoma and Non-Acute Leukemia with Other Procedures with CC (12 of 15 codes)
- DRG 825 Lymphoma and Non-Acute Leukemia with Other Procedures without CC/MCC (12 of 15 codes)
- DRG 840 Lymphoma and Non-Acute Leukemia with MCC (12 of 15 codes)
- DRG 841 Lymphoma and Non-Acute Leukemia with CC (12 of 15 codes)
- DRG 842 Lymphoma and Non-Acute Leukemia without CC/MCC (12 of 15 codes)
- DRG 834 Acute Leukemia with MCC (3 of 15 codes)
- DRG 835 Acute Leukemia with CC (3 of 15 codes)
- DRG 836 Acute Leukemia without CC/MCC (3 of 15 codes)
- DRG 837 Chemotherapy with Acute Leukemia as Secondary Diagnosis or with High Dose Chemotherapy Agent with MCC (3 of 15 codes)
- DRG 838 Chemotherapy with Acute Leukemia as Secondary Diagnosis with CC or High Dose Chemotherapy Agent (3 of 15 codes)
- DRG 839 Chemotherapy with Acute Leukemia as Secondary Diagnosis without CC/MCC (3 of 15 codes)
- DRG 850 Acute Leukemia with Other Procedures (3 of 15 codes)
Other codes that refer to C93
Notes on these codes point to C93.
- D72.825 Excludes1: leukemia (C91.-, C92.-, C93.-, C94.-, C95.-)
About the condition
Plain-language background from MedlinePlus (National Library of Medicine), not coding guidance.
Acute Myeloid Leukemia
Leukemia is a term for cancers of the blood cells. Leukemia starts in blood-forming tissues such as the bone marrow. Your bone marrow makes the cells which will develop into white blood cells, red blood cells, and platelets. Each type of cell has a different job:
Read more about acute myeloid leukemia on MedlinePlusChronic Myeloid Leukemia
Leukemia is a term for cancers of the blood cells. Leukemia starts in blood-forming tissues such as the bone marrow. Your bone marrow makes the cells which will develop into white blood cells, red blood cells, and platelets. Each type of cell has a different job:
Read more about chronic myeloid leukemia on MedlinePlusCode history
Valid since FY2016, when ICD-10-CM took effect on October 1, 2015. No changes since.
